Clovis Oncology's Rubraca shows promise for prostate cancer in phase 1 trial
April 11 2021 - 10:00AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Sep 2023 to Sep 2024